ATNF
180 Life Sciences$2.16
ATNF info-2.70%ย โ€ข 24 H
Dividend Yield:-
Global Rank#29531
Market Cap$4.10M
YTD Performance948.54%
P/E-0.11
Revenue$0
Change 7d-1.82%
SP500 BenchmarkOutperform
P/S0
Earnings-$38.73M

180 Life Sciences (ATNF) Stock Overview

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

ATNF Stock Information

SymbolATNF
Address
Building 4Palo Alto, CA 94306United States
Founded-
Trading hours-
Websitehttps://180lifesciences.com
Country๐Ÿ‡บ๐Ÿ‡ธ United States
Phone Number650 507 0669

180 Life Sciences (ATNF) Price Chart

-
Value:-

180 Life Sciences Overview: Key Details and Summary

Stock data
2022
Change
Price
$2.16
N/A
Market Cap
$4.10M
N/A
Shares Outstanding
1.90M
21.22%
Employees
5.00
N/A
Shareholder Equity
11.34M
-71.15%
Valuation
2022
Change
P/E Ratio
-0.11
N/A
P/B Ratio
0.36
N/A
Growth
2022
Change
Return on Equity
-3.4138
N/A
Earnings
2022
Change
Revenue
$0
N/A
Earnings
-$38.73M
N/A
EPS
-20.38
N/A
Earnings Yield
-9.44
N/A
Financial Strength
2022
Change
Total Assets
$19.65M
N/A
Total Debt
$1.34M
N/A
Cash on Hand
$6.97M
N/A
Debt to Equity
0.7322
23.10%
Cash to Debt
$5.20
23.83%
Current Ratio
$1.58
177.53%
ยฉ 2024 TopStocks.org
Facebook Icon
Twitter Icon
Linkedin Icon